Penta-N-methylated peptide
Penta-N-methylated peptide has been studied in 1 paper since 2009: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Dec 24, 2009: “Poly-N-methylated amyloid beta-peptide (Abeta) C-terminal fragments reduce Abeta toxicity in vitro and in Drosophila melanogaster”.
1 paper studies it2 findingsUpdated
None of its findings points the other way.
- 1 lab in 1 country
- Model organisms1
What did studies of Penta-N-methylated peptide find?
2Studies of Penta-N-methylated peptide measured 2 outcomes; the most studied are locomotor activity (1 study) and lifespan (1).
Locomotor activity
upin flies1
1 study
Locomotor activity
upin flies1
Penta-N-methylated peptide improves locomotor activity in flies.
“This penta-N-methylated peptide moreover increased life span and locomotor activity in Drosophila melanogaster flies overexpressing human Abeta(1-42).”
Model organismsoverexpressing human Abeta(1-42)
Journal of medicinal chemistry
Lifespan
upin flies1
1 study
Lifespan
upin flies1
Penta-N-methylated peptide extends lifespan in flies.
“This penta-N-methylated peptide moreover increased life span and locomotor activity in Drosophila melanogaster flies overexpressing human Abeta(1-42).”
Model organismsoverexpressing human Abeta(1-42)
Journal of medicinal chemistry